Clinical Trial Update: Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence [NA]

View source ↗

Summary

A completed clinical trial sponsored by NIDA evaluated how well buprenorphine/naloxone blocks opioid effects in people with opioid use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Buprenorphine/naloxone (buprenorphine/naloxone)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Opioid-Related Disorders | NA | Status: COMPLETED